New imaging agent aims to light up tumors for better detection
NCT ID NCT07505069
First seen Apr 08, 2026 · Last updated May 25, 2026 · Updated 9 times
Summary
This early-phase study is testing a new radioactive imaging agent called RT01-89Zr. It is designed to attach to a protein (TF) found on many solid tumor cells, so doctors can see the tumors on a PET/CT scan. The study will enroll about 10 adults with solid tumors to check the safety of the agent and how well it shows where the tumors are in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
RECRUITINGWuxi, Jiangsu, 214122, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.